Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques

Atherosclerosis

Volumn 164, Issue 1, 2002, Pages 79-87

  Ma, Harry ^a   Calderon, Tina M ^a   Fallon, John T ^b   Berman, Joan W ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Atherosclerosis; Endothelium; Hepatocyte growth factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; SCATTER FACTOR; TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SCATTER FACTOR RECEPTOR;

ANGIOGENESIS; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CAROTID ARTERY; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; LIVER CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURVIVAL; TARGET CELL; UMBILICAL CORD; ARTERIOSCLEROSIS; CELL CULTURE; CYTOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; ARTERIOSCLEROSIS; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HEPATOCYTE GROWTH FACTOR; HUMAN; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROTO-ONCOGENE PROTEIN C-MET; UMBILICAL VEINS; HUMANS; PROTO-ONCOGENE PROTEINS C-MET;

EID: 0035996581     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00062-X     Document Type: Article

References (44)

1. Hepatocyte growth factor modulates migration and proliferation of human microvascular endothelial cells in culture
2. Scatter factor induces blood vessel formation in vivo
3. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells
4. Autocrine FGF-2 is responsible for the cell density-dependent susceptibility to apoptosis of HUVEC: A role of a calpain inhibitor-sensitive mechanism
5. Serum hepatocyte growth factor in patients with peripheral arterial occlusive disease
6. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF
7. Apoptosis participates in cellularity regulation during rat aortic intimal thickening
8. Apoptotic vascular endothelial cells become procoagulant
9. Apoptosis in the vascular wall and atherosclerosis
10. Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro
11. Single low-dose administration of human recombinant hepatocyte growth factor attenuates intimal hyperplasia in a balloon-injured rabbit iliac artery model
12. In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model
13. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: Downregulation of HGF in response to hypoxia in vascular cells
14. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model [see comments]
15. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: Up-regulation of essential transcription factor for angiogenesis, ets
16. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways
17. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways
18. Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apoptosis via the phosphatidylinositol-3 kinase/Akt pathway
19. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
20. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
21. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
22. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
23. Transcriptional repression by rb-e2f and regulation of anchorage-independent survival
24. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling
25. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium
26. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
27. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NF kappa B in human-endothelial cells
28. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion
29. NF-kappa B mediates alphavbeta3 integrin-induced endothelial cell survival
30. Inhibition of human endothelial cell chemokine production by the opportunistic fungal pathogen Cryptococcus neoformans
31. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
32. Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death
33. Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF
34. Macrophages, smooth muscle cells, and tissue factor in unstable angina: Implications for cell-mediated thrombogenicity in acute coronary syndromes
35. The Intima: Soil for atherosclerosis and restenosis
36. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms
37. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase
38. Anti-apoptotic action of hepatocyte growth factor through mitogen-activated protein kinase on human aortic endothelial cells
39. Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release
40. Endothelin is a potent mitogen for rat vascular smooth muscle cells
41. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
42. Hepatocyte growth factor-stimulated invasiveness of monocytes
43. Interaction between monocytes and vascular smooth muscle cells induces expression of hepatocyte growth factor [in process citation]
44. Hepatocyte growth factor enhances MMP activity in human endothelial cells